Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ele Ferrannini

Showing results (341-350 of 408) with videos related to

Pageof 41
Sort By:
Nuclear Medicine and Biology|May 25, 2006
[11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemiaLetizia Guiducci, Mikko Järvisalo, Jan Kiss, et al.
Diabetes Care|January 22, 2017
Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201William T Cefalu, John B Buse, Jaakko Tuomilehto, et al.
Atherosclerosis|January 21, 2018
High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individualsRain Yamamoto, Frank M Sacks, Frank B Hu, et al.
Diabetes Care|January 25, 2019
Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy: A Subanalysis of the EMPA-REG OUTCOME TrialSubodh Verma, C David Mazer, Deepak L Bhatt, et al.
Diabetes|November 20, 2012
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significanceEle Ferrannini, Andrea Natali, Stefania Camastra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2007
Biodistribution of the fatty acid analogue 18F-FTHA: plasma and tissue partitioning between lipid pools during fasting and hyperinsulinemiaLetizia Guiducci, Tove Grönroos, Mikko J Järvisalo, et al.
Diabetes|September 7, 2007
Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell functionLaura Pascoe, Andrea Tura, Sheila K Patel, et al.
Diabetes Care|December 6, 2017
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME TrialSilvio E Inzucchi, Bernard Zinman, David Fitchett, et al.
Plos One|June 8, 2010
alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic populationWalter E Gall, Kirk Beebe, Kay A Lawton, et al.
International Journal of Molecular Sciences|June 13, 2025
Circulating N-Acetylaspartate Levels Associate with Measures of Peripheral and Tissue-Specific Insulin SensitivityEleni Rebelos, Miikka-Juhani Honka, Aino Latva-Rasku, et al.
Pageof 41

Showing results (341-350 of 408) with videos related to

Sort By:
Pageof 41
Nuclear Medicine and Biology|May 25, 2006
[11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemiaLetizia Guiducci, Mikko Järvisalo, Jan Kiss, et al.
Diabetes Care|January 22, 2017
Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201William T Cefalu, John B Buse, Jaakko Tuomilehto, et al.
Atherosclerosis|January 21, 2018
High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individualsRain Yamamoto, Frank M Sacks, Frank B Hu, et al.
Diabetes Care|January 25, 2019
Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy: A Subanalysis of the EMPA-REG OUTCOME TrialSubodh Verma, C David Mazer, Deepak L Bhatt, et al.
Diabetes|November 20, 2012
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significanceEle Ferrannini, Andrea Natali, Stefania Camastra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2007
Biodistribution of the fatty acid analogue 18F-FTHA: plasma and tissue partitioning between lipid pools during fasting and hyperinsulinemiaLetizia Guiducci, Tove Grönroos, Mikko J Järvisalo, et al.
Diabetes|September 7, 2007
Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell functionLaura Pascoe, Andrea Tura, Sheila K Patel, et al.
Diabetes Care|December 6, 2017
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME TrialSilvio E Inzucchi, Bernard Zinman, David Fitchett, et al.
Plos One|June 8, 2010
alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic populationWalter E Gall, Kirk Beebe, Kay A Lawton, et al.
International Journal of Molecular Sciences|June 13, 2025
Circulating N-Acetylaspartate Levels Associate with Measures of Peripheral and Tissue-Specific Insulin SensitivityEleni Rebelos, Miikka-Juhani Honka, Aino Latva-Rasku, et al.
Pageof 41